WAVEMAN · COMPANY

AVR · Anteris Technologies Global Corp.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

AVR

Name: Anteris Technologies Global Corp. (AVR) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Anteris Technologies Global Corp.

MEDICAL DEVICES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · CIK 0002011514

SEC FILINGS☆ WATCH

INSIDER NET · 180D

-$25.1M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-29.2%

XBRL, annual

NET MARGIN

-4921.3%

CONVERSIONS · 180D

codes C/M, not in net · $727.9K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$25.1M over 180 days

-$25.2M over 90 days · -$25.2M of it by a 10%+ holder

below 91% of Medical Devices

CONGRESS

no member of Congress has reported trading it

FUNDS

84 funds added or opened last quarter

more than 53% of Medical Devices

REVENUE

-29.2% year over year

below 92% of Medical Devices

MARGIN

-4921.3% net margin

the lowest in Medical Devices

BUYBACKS

no share repurchases reported

SHORT

7.3% of shares outstanding short · 6.9 days to cover · settled 2026-07-31

more than 77% of Medical Devices

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

84 funds added or opened positions in the latest 13F quarter, of 138 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +120.0%

+120.0%12M

INSIDER BUYINSIDER SELL13D/G STAKE

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $25.1M sold by insiders over 180 days, 84 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Anteris Technologies Global Corp. insiders sold a net $25.1M of stock across 16 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

L1 Capital Pty Ltd

—

SELL

2026-08-28

7,800.0

$68.9K

L1 Capital Pty Ltd

—

SELL

2026-08-11

375,815.0

$3.5M

L1 Capital Pty Ltd

—

SELL

2026-08-10

251,844.0

$2.3M

L1 Capital Pty Ltd

—

SELL

2026-08-06

174,721.0

$1.4M

L1 Capital Pty Ltd

—

SELL

2026-08-05

14,581.0

$120.0K

16 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 11 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

L1 Capital Pty Ltd

7,789,000.0 sh

$76.7M

FMR LLC

6,868,086.0 sh

$67.7M

Nantahala Capital Management, LLC

6,766,670.0 sh

$66.7M

BlackRock, Inc.

5,771,213.0 sh

$56.8M

Sio Capital Management, LLC

5,545,984.0 sh

$54.6M

5%+ owners

13D = intent to influence · 13G = passive

Medtronic plc

ACTIVIST 13D · 2026-01-29

16.2%

Covidien Group S.a.r.l.

ACTIVIST 13D · 2026-01-29

16.2%

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Fidelity Pacific Basin Fund

$11.0M POSITION · AS OF 2026-04-30

0.9%

Ultra-Small Company Market Fund

$333.0K POSITION · AS OF 2026-03-31

0.3%

Fidelity International Small Cap Opportunities Fund

$2.8M POSITION · AS OF 2026-04-30

0.2%

iShares Micro-Cap ETF

$1.1M POSITION · AS OF 2026-03-31

0.1%

Fidelity Series International Small Cap Fund

$2.2M POSITION · AS OF 2026-04-30

0.1%

Fidelity SAI High Income Fund

$1.2M POSITION · AS OF 2026-04-30

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12
REVENUE	$1.9M	$2.7M
OPERATING INCOME	$-93.9M	$-78.4M
NET INCOME	$-94.1M	$-76.3M
EPS (DILUTED)	-2.55	-3.68
OPERATING CASH FLOW	$-77.8M	$-61.2M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE